Mercator Launches Trial Of Micro-Infusion Device For Lower-Leg Obstruction

LIMBO-ATX will evaluate adventitial delivery of dexamethasone after atherectomy-based revascularizations of lesions below the knee were noted in symptomatic patients with critical limb ischemia.